VALU's Q2 Earnings Flat Y/Y, Gains on Strong EAM Trust Contributions
ZACKS· 2025-12-19 15:46
Core Insights - Value Line, Inc. (VALU) shares increased by 3.6% following the earnings report for the quarter ended October 31, 2025, outperforming the S&P 500 index, which declined by 1.7% during the same period [1] - For the fiscal second quarter of 2026, the company reported earnings per share (EPS) of 60 cents, consistent with the previous year's quarter [1] Financial Performance - Total publishing revenues decreased by 3.2% to $8.6 million from $8.8 million in the prior year, driven by declines in investment periodicals and copyright fees [2] - Net income remained stable at $5.68 million, nearly unchanged from $5.69 million a year earlier [2] - Strong performance from equity interests in EAM Trust contributed $5.2 million in revenues, an 11.3% increase from $4.6 million a year ago [3] - Investment gains totaled $1.2 million, unchanged from the previous year, supported by $0.4 million in unrealized gains on equity holdings [4] Management Insights - The company emphasized its focus on proprietary investment research and analytics for both retail and institutional clients, highlighting a stable business model [5] - Continued reliance on recurring subscription revenue was noted, with most products delivered digitally or in print via annual subscriptions [6] Cost Management - Total expenses remained flat at $7 million, with salaries and employee benefits slightly decreasing to $3.5 million [7] - Cost discipline helped mitigate the decline in publishing revenue [7] Cash Position and Future Outlook - Cash and cash equivalents improved to $43.6 million from $34.1 million six months earlier, supported by strong operating cash flows of $8.5 million in the first half of fiscal 2026 [8] - Unearned revenues, an indicator of future subscription fulfillment, decreased slightly to $20.3 million from $22.3 million in April 2025 [8] Share Repurchase Program - The board approved a new share repurchase program authorizing up to $2 million in buybacks, with 4,194 shares repurchased during the quarter at an average cost of $26.68 per share [9] - An additional 14,015 shares were repurchased on November 17, 2025, at $37 per share via a private block offering [9]
Veeva Systems (VEEV) is a Top-Ranked Growth Stock: Should You Buy?
ZACKS· 2025-12-19 15:46
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed along ...
Here's Why Zscaler (ZS) is a Strong Growth Stock
ZACKS· 2025-12-19 15:46
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style S ...
Trump to announce new drug-pricing deals later today
MarketWatch· 2025-12-19 15:45
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices. ...
Broadcom vs. AMD: Which AI Chip Stock Will Outperform in 2026?
Yahoo Finance· 2025-12-19 15:45
Key Points AMD is looking to carve a niche in the inference market. Broadcom has a massive opportunity with custom AI chips. The stocks trade at similar valuations. 10 stocks we like better than Advanced Micro Devices › Two of the top semiconductor companies looking to eat into Nvidia's (NASDAQ: NVDA) artificial intelligence (AI) infrastructure dominance are Broadcom (NASDAQ: AVGO) and Advanced Micro Devices (NASDAQ: AMD). Both stocks have performed well in 2025, led by AMD, which is up more than ...
What is the personal savings rate in the U.S., and how does yours compare?
Yahoo Finance· 2025-12-19 15:44
You know saving money is important — it’s what allows you to achieve goals such as buying a house, retiring comfortably, or even going on vacation next year. But balancing saving with spending is a universal challenge, and one that doesn’t have a one-size-fits-all solution. That’s where your personal savings rate comes in. Your personal savings rate is a measure of how much disposable income you’re able to save. Knowing this number can help you set reasonable financial goals and stay on track to reach the ...
Union Pacific kicks off regulatory review for $85 bln coast‑to‑coast rail merger
Reuters· 2025-12-19 15:44
Union Pacific and Norfolk Southern on Friday filed a nearly 7,000page merger application with the U.S. Surface Transportation Board (STB), triggering a 30day period in which the regulator can seek m... ...
Oracle and OpenAI Win Michigan Approval to Power New Data Center
Yahoo Finance· 2025-12-19 15:43
Michigan regulators unanimously approved a request from utility DTE Energy Co. to power a massive data center development planned by Oracle and OpenAI, during a contentious hearing where some members of the public pushed back on the project. DTE had asked regulators for expedited approval of its plan to power the multi-billion dollar, 1.4-gigawatt facility in Saline Township. Each of the regulators said Thursday the proposed contracts between the utility and tech firms protected the power grid and regular ...
Nxera seeks schizophrenia programme buyer after Boehringer snub
Yahoo Finance· 2025-12-19 15:42
Japan-based Nxera Pharma is seeking buyers for its Phase II-ready schizophrenia programme after Boehringer Ingelheim decided not to exercise a licensing option. Boehringer Ingelheim, which held exclusive rights to license the neurological disorder portfolio of GPR52 agonists, did not provide further information to Nxera. Rights to the programme will now revert to the Japanese biotech. Nxera said it is now exploring strategic opportunities for the programme, including a licensing partnership with a major ...
Meta Joins the AI Video Race: Report. It Needs to Catch Google and OpenAI.
Barrons· 2025-12-19 15:42
Google's Veo and Nano Banana and OpenAI's Sora are tough competition. ...